Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation
20.38 +0.31 (1.54%)
- Ринкова капіталізація
- $1.16B
- Обсяг торгів
- 1.57M
- Наступна дата звітності
- Nov 4, 2026
PROCEPT BioRobotics Corporation (PRCT): ціна акції, аналіз і дані
Внутрішня вартість
Прогноз аналітиків
Прогнози по акціях →Останні результати
| Факт | До прогнозу | Зміна р/р | |
|---|---|---|---|
| Виручка | $94.50M | n/a | +19.34% |
| EPS | -$0.47 | -$0.02 | -34.29% |
Показники
- Купівля
- 13.9
- Ринкова капіталізація
- 1.16B
- Виручка (ttm)
- 337M
- Чистий прибуток (ttm)
- -110M
- 0.90
- -1.95
- n/a
- -17.68
- P/B (ttm)
- 3.43
- P/S (ttm)
- 3.46
- Дата звіту
- Nov 4, 2026
- Продаж
- 22.04
- Обсяг торгів
- 1,573,244
- Сер. обсяг (20 дн.)
- 1,582,977
- Відкриття
- 20.53
- Попереднє закриття
- 20.07
- Діапазон дня
- 19.55 - 20.67
- Діапазон за 52 тижні
- 16.66 - 40.10
- Аналітик
- n/a
- Цільова ціна
- n/a
- Дивіденди
- n/a
- Екс-дивідендна дата
- n/a
Про PROCEPT BioRobotics Corporation
Профіль →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Галузь Medical Devices
Сектор Healthcare
Дата IPO Sep 15, 2021
Працівники 888
Біржа NasdaqGM
Тікер PRCT